Literature DB >> 17329743

Anterior cingulate grey-matter deficits and cannabis use in first-episode schizophrenia.

Philip R Szeszko1, Delbert G Robinson, Serge Sevy, Sanjiv Kumra, Claudia I Rupp, Julia D Betensky, Todd Lencz, Manzar Ashtari, John M Kane, Anil K Malhotra, Handan Gunduz-Bruce, Barbara Napolitano, Robert M Bilder.   

Abstract

BACKGROUND: Despite the high prevalence of cannabis use in schizophrenia, few studies have examined the potential relationship between cannabis exposure and brain structural abnormalities in schizophrenia. AIMS: To investigate prefrontal grey and white matter regions in patients experiencing a first episode of schizophrenia with an additional diagnosis of cannabis use or dependence (n=20) compared with similar patients with no cannabis use (n=31) and healthy volunteers (n=56).
METHOD: Volumes of the superior frontal gyrus, anterior cingulate gyrus and orbital frontal lobe were outlined manually from contiguous magnetic resonance images and automatically segmented into grey and white matter.
RESULTS: Patients who used cannabis had less anterior cingulate grey matter compared with both patients who did not use cannabis and healthy volunteers.
CONCLUSIONS: A defect in the anterior cingulate is associated with a history of cannabis use among patients experiencing a first episode of schizophrenia and could have a role in poor decision-making and in choosing more risky outcomes.

Entities:  

Mesh:

Year:  2007        PMID: 17329743     DOI: 10.1192/bjp.bp.106.024521

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  32 in total

Review 1.  Structural cerebral variations as useful endophenotypes in schizophrenia: do they help construct "extended endophenotypes"?

Authors:  Konasale M Prasad; Matcheri S Keshavan
Journal:  Schizophr Bull       Date:  2008-04-11       Impact factor: 9.306

Review 2.  Anatomical abnormalities of the anterior cingulate cortex in schizophrenia: bridging the gap between neuroimaging and neuropathology.

Authors:  Alex Fornito; Murat Yücel; Brian Dean; Stephen J Wood; Christos Pantelis
Journal:  Schizophr Bull       Date:  2008-04-23       Impact factor: 9.306

3.  Impact of substance use disorder on gray matter volume in schizophrenia.

Authors:  Margaret Quinn; Maureen McHugo; Kristan Armstrong; Neil Woodward; Jennifer Blackford; Stephan Heckers
Journal:  Psychiatry Res Neuroimaging       Date:  2018-08-03       Impact factor: 2.376

Review 4.  Neuroimaging Studies in Patients With Mental Disorder and Co-occurring Substance Use Disorder: Summary of Findings.

Authors:  Kaloyan Rumenov Stoychev
Journal:  Front Psychiatry       Date:  2019-10-23       Impact factor: 4.157

5.  Lack of Evidence for Regional Brain Volume or Cortical Thickness Abnormalities in Youths at Clinical High Risk for Psychosis: Findings From the Longitudinal Youth at Risk Study.

Authors:  Paul Klauser; Juan Zhou; Joseph K W Lim; Joann S Poh; Hui Zheng; Han Ying Tng; Ranga Krishnan; Jimmy Lee; Richard S E Keefe; R Alison Adcock; Stephen J Wood; Alex Fornito; Michael W L Chee
Journal:  Schizophr Bull       Date:  2015-03-04       Impact factor: 9.306

6.  Cannabis use and cognitive function in first episode psychosis: differential effect of heavy use.

Authors:  Christian Núñez; Susana Ochoa; Elena Huerta-Ramos; Iris Baños; Ana Barajas; Montserrat Dolz; Bernardo Sánchez; Núria Del Cacho; Judith Usall
Journal:  Psychopharmacology (Berl)       Date:  2015-12-01       Impact factor: 4.530

Review 7.  Endocannabinoid system: potential novel targets for treatment of schizophrenia.

Authors:  Atsushi Saito; Michael D L Ballinger; Mikhail V Pletnikov; Dean F Wong; Atsushi Kamiya
Journal:  Neurobiol Dis       Date:  2012-12-07       Impact factor: 5.996

8.  Thalamo-frontal white matter alterations in chronic schizophrenia: a quantitative diffusion tractography study.

Authors:  Jungsu S Oh; Marek Kubicki; Gudrun Rosenberger; Sylvain Bouix; James J Levitt; Robert W McCarley; Carl-Fredrik Westin; Martha E Shenton
Journal:  Hum Brain Mapp       Date:  2009-11       Impact factor: 5.038

9.  Lifetime use of cannabis from longitudinal assessments, cannabinoid receptor (CNR1) variation, and reduced volume of the right anterior cingulate.

Authors:  Shirley Y Hill; Vinod Sharma; Bobby L Jones
Journal:  Psychiatry Res Neuroimaging       Date:  2016-07-19       Impact factor: 2.376

Review 10.  The effect of cannabis on the brain: can it cause brain anomalies that lead to increased risk for schizophrenia?

Authors:  Lynn E DeLisi
Journal:  Curr Opin Psychiatry       Date:  2008-03       Impact factor: 4.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.